Article Figures & Data
Figures
- Figure 1. Diabetes intervention (ACM) and control (TTR-only) care package details. ACM = additional case management. BP = blood pressure. FBG = fasting blood glucose. RBG = random blood glucose. TTR = testing, treating, and recording.
- Figure 2. CONSORT trial flow chart
ACM = additional case management. TTR = testing, treating, and recording.
Tables
Characteristics ACM, n (%) TTR-only, n (%) Clusters Total 7 (100.0) 7 (100.0) Doctors Male 7 (100.0) 7 (100.0) Female 0 (0.0) 0 (0.0) Paramedics Male 5 (71.4) 3 (42.9) Female 2 (28.6) 4 (57.1) Participants in clusters Total 250 (50.5) 245 (49.5) Mean cluster size (SD) 35.7 (± 10.4) 35 (± 15.4) Sex Male 92 (36.8) 97 (39.6) Female 158 (63.2) 148 (60.4) Mean age, years (SD) 46.1 (± 10.4) 46.1 (± 9.7) Mean education ,years (SD) 3.5 (± 4.4) 4.9 (± 4.8) Mean BMI, kg/m2 (SD) 31.9 (± 7.8) 32.8 (± 8.1) Hypertensive 60 (24.0) 68 (27.8) Mean fasting blood sugar, mg/dL (SD) 216.3 (± 56.5) 203.8 (± 52.7) Mean random blood sugar, mg/dL (SD) 303.3 (± 81.6) 292.7 (± 69.5) Mean HbA1c% (SD) 10.4 (± 2.4) 10.0 (± 2.4) Mean systolic blood pressure, mmHg (SD) 129.9 (± 16.6) 130.1 (± 17.6) Mean diastolic blood pressure, mmHg (SD) 84.7 (± 9.4) 87.0 (± 13.3) Mean total serum cholesterol, mg/dL (SD) 192.6 (± 51.8) 193.0 (± 46.6) 'Hypertensive' defined as baseline systolic blood pressure >140 mmHg.
ACM = additional case management. BMI = body mass index. TTR = testing, treating, and recording
ACM arm
(clusters, n = 7)TTR-only arm
(clusters, n = 7)Crude ACM-TTR difference
(95% CI); P valueaAdjusted ACM-TTR
difference (95% CI); P valueaMean outcome (95% CI)b Primary outcome Change in HbA1c (pp)c -2.26pp (-2.99 to -1.53) -1.44pp (-2.34 to -0.54) -0.82pp (-1.86 to 0.21); 0.11 -0.57pp (-1.44 to 0.29); 0.17 Secondary outcomes Adherenced 75.64% (45.56 to 105.71%) 36.29% (3.9 to 68.67%) 39.35pp (-0.02 to 78.73); 0.0501 36.06pp (-0.78 to 72.9); 0.054 Glycaemic controle 45.04% (32.48 to 57.6%) 34.86% (16.15 to 53.57%) 10.18pp (-10.21 to 30.57); 0.29 10.87pp (-7.92 to 29.67); 0.23 Change in SBP (mmHg)c 2.33 (-0.1 to 4.76) 1.47 (-4.32 to 7.26) 0.86 (-5.05 to 6.77); 0.75 1.3 (-3.41 to 6.01); 0.56 Change in DBP (mm Hg)c 2.81 (-1.04 to 6.66) 0.68 (-4.34 to 5.69) 2.13 (-3.54 to 7.81); 0.43 0.29 (-1.93 to 2.51); 0.78 Hypertension controlf 73.2% (61.92 to 84.49%) 72.47% (59.36 to 85.58%) 0.73pp (-14.71 to 16.17); 0.92 0.0pp (-12 to 12.95); 0.93 Change in total serum
cholesterol (mg/dL)c-5.24 (-19.82 to 9.34) 2.75 (-5.73 to 11.22) -7.99 (-23.43 to 7.45); 0.27 -5.79 (-20.22 to 8.65); 0.4 ACM = additional case management. CI = confidence intervals. TTR = test, treat, and record. PP = percentage points.
aAll ACM–TTR differences (that is, ACM effect size measures) are based on analysis of cluster-level (mean/proportion) outcomes. bMean outcomes and their 95% confidence intervals are based on cluster-level (mean/proportion) raw outcome data. cAll change outcomes are calculated as outcome at 9 months minus outcome at baseline. dAdherence defined as attendance of ≥4 follow-up appointments within 9 months. eGlycaemic control defined as 9-month HbA1c (%) <7%. fHypertension control defined as 9-month systolic blood pressure ≤140 mmHg.
All analyses exclude patients’ missing outcome and/or covariate data as required by the relevant analysis.
In this issue
Jump to section
More in this TOC Section
Related Articles
Cited By...
